Automated drug discovery company Arctoris has opened entries to it’s global business competition for drug discovery entrepreneurs.
BioTarget 2020 is now open for applications and is directed at identifying and supporting emerging biotech companies dedicated to innovation within drug discovery. Arctoris awards a total of more than $150,000 worth of free experiments on its robotic platform to the winners selected by a world-class panel of thought-leaders in drug discovery.
Companies are invited to apply online by 24 May 2020. The eight most promising applicants – based on scientific quality, progress to date, and clinical need – will be selected to compete for three prizes in a final pitch event to be held in Boston, MA, on 15 June 2020. Application is free of charge – including the trip to Boston for the eight finalists.
Martin-Immanuel Bittner, CEO of Arctoris, said: “BioTarget 2020 is directed at early-stage ventures aiming to develop new molecules for drug discovery. It also aims to raise awareness of entrepreneurship and innovation amongst scientists, allowing them to showcase their innovations to a great audience, gain feedback from thought-leaders in the field, and meet and learn from leading biotech investors and industry professionals who can help to move ideas forward.”
ioTarget 2020 is open to anyone in any discipline with a drive to characterise or validate a drug target using cell-based, molecular biology or biochemical assays. Applicants can include clinicians, software engineers, postdoctoral researchers, established professors, entrepreneurs running a virtual biotech company or even undergraduate students - it’s the quality of the idea that counts and not the position.